These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 18824992)
41. [Use of the radiosurgery knife in the treatment of hypophyseal adenomas]. Vladyka V; Liscák R; Subrt O; Simonová G; Novotný J Cas Lek Cesk; 1995 Sep; 134(17):539-42. PubMed ID: 7553756 [TBL] [Abstract][Full Text] [Related]
42. Gamma knife radiosurgery for central neurocytoma: retrospective analysis of fourteen cases with a median follow-up period of sixty-five months. Chen MC; Pan DH; Chung WY; Liu KD; Yen YS; Chen MT; Wong TT; Shih YH; Wu HM; Guo WY; Shiau CY; Wang LW; Lin CW Stereotact Funct Neurosurg; 2011; 89(3):185-93. PubMed ID: 21546789 [TBL] [Abstract][Full Text] [Related]
43. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly. Bastemir M; Akin F; Yaylali GF Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378 [TBL] [Abstract][Full Text] [Related]
44. Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. Sheehan JP; Pouratian N; Steiner L; Laws ER; Vance ML J Neurosurg; 2011 Feb; 114(2):303-9. PubMed ID: 20540596 [TBL] [Abstract][Full Text] [Related]
45. Changes in the volume of residual pituitary adenomas in patients with adult-onset growth hormone deficiency during replacement therapy with the recombinant human growth hormone. Finkenstedt G; Höfle G; Pallua A; Sailer U; Gasser RW Wien Klin Wochenschr; 1999 Nov; 111(21):887-90. PubMed ID: 10599151 [TBL] [Abstract][Full Text] [Related]
47. Volumetric follow-up of meningiomas: a quantitative method to evaluate treatment outcome of gamma knife radiosurgery. Feigl GC; Samii M; Horstmann GA Neurosurgery; 2007 Aug; 61(2):281-6; discussion 286-7. PubMed ID: 17762740 [TBL] [Abstract][Full Text] [Related]
48. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Paek SH; Downes MB; Bednarz G; Keane WM; Werner-Wasik M; Curran WJ; Andrews DW Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):795-808. PubMed ID: 15708259 [TBL] [Abstract][Full Text] [Related]
49. Predictors of outcome following Gamma Knife surgery for acromegaly. Poon TL; Leung SC; Poon CY; Yu CP J Neurosurg; 2010 Dec; 113 Suppl():149-152. PubMed ID: 21222293 [TBL] [Abstract][Full Text] [Related]
50. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease. Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356 [TBL] [Abstract][Full Text] [Related]
51. Gamma knife radiosurgery for glomus jugulare tumors: volumetric analysis in 17 patients. Varma A; Nathoo N; Neyman G; Suh JH; Ross J; Park J; Barnett GH Neurosurgery; 2006 Nov; 59(5):1030-6; discussion 1036. PubMed ID: 17143237 [TBL] [Abstract][Full Text] [Related]
52. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly. Gradiser M; Matovinovic M; Vrkljan M Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144 [TBL] [Abstract][Full Text] [Related]